Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1532 to 1581 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein 10 (rna binding motif protein 10) (dxs8237e). [source:swissprot;acc:p98175]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYCS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome c. [source:swissprot;acc:p00001]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HS6ST2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase 2. [source:refseq;acc:nm\_147174]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HS6ST1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase; heparan-sulfate 6-sulfotransferase. [source:refseq;acc:nm\_004807]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FA2H\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fatty acid hydroxylase domain containing 1. [source:refseq;acc:nm\_024306]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WBP11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ww domain binding protein 11; npw38-binding protein npwbp; sh3 domain-binding protein snp70. [source:refseq;acc:nm\_016312]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elac homolog 2; putative prostate cancer susceptibility protein; elac (e. coli) homolog 2. [source:refseq;acc:nm\_018127]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein 5 (rna binding motif protein 5) (putative tumor suppressor luca15) (g15 protein). [source:swissprot;acc:p52756]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
autophagy protein 5-like (apg5-like) (apoptosis-specific protein). [source:swissprot;acc:q9h1y0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.077\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01721\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myb proto-oncogene protein (c-myb). [source:swissprot;acc:p10242]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.672\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01714\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMLHE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trimethyllysine dioxygenase, mitochondrial precursor (ec 1.14.11.8) (epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (tml-alpha- ketoglutarate dioxygenase) (tml hydroxylase) (tml dioxygenase) (tmld). [source:swissprot;acc:q9nvh6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.546\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.965\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01706\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ERAL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gtp-binding protein era homolog (hera) (fragment). [source:swissprot;acc:o75616]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NR2E1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
orphan nuclear receptor nr2e1 (nuclear receptor tlx) (tailless homolog) (tll) (htll). [source:swissprot;acc:q9y466]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01704\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NR2C1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
orphan nuclear receptor tr2. [source:swissprot;acc:p13056]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.083\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01702\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ASS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
argininosuccinate synthase (ec 6.3.4.5) (citrulline--aspartate ligase). [source:swissprot;acc:p00966]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.474\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01701\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1547\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYBL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myb-related protein b (b-myb). [source:swissprot;acc:p10244]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.541\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01699\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1548\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYBL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myb-related protein a (a-myb). [source:swissprot;acc:p10243]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.802\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01696\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1549\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DCTN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dynactin complex 50 kda subunit (50 kda dynein-associated polypeptide) (dynamitin) (dctn-50) (dynactin 2). [source:swissprot;acc:q13561]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01687\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1550\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC25A6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC25A4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adp,atp carrier protein, heart/skeletal muscle isoform t1 (adp/atp translocase 1) (adenine nucleotide translocator 1) (ant 1). [source:swissprot;acc:p12235]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC25A5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adp,atp carrier protein, fibroblast isoform (adp/atp translocase 2) (adenine nucleotide translocator 2) (ant 2). [source:swissprot;acc:p05141]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AHCY\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenosylhomocysteinase (ec 3.3.1.1) (s-adenosyl-l-homocysteine hydrolase) (adohcyase). [source:swissprot;acc:p23526]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.389\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.833\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01679\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c-terminal binding protein 1 (ctbp1). [source:swissprot;acc:q13363]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.215\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.018\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01656\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PASK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pas domain containing serine/threonine kinase; pas-serine/threonine kinase. [source:refseq;acc:nm\_015148]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
196.192\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
192.996\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BCL6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
b-cell lymphoma 6 protein (bcl-6) (zinc finger protein 51) (laz-3 protein) (bcl-5). [source:swissprot;acc:p41182]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNAI2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein slug (neural crest transcription factor slug) (snail homolog 2). [source:swissprot;acc:o43623]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTBP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c-terminal binding protein 2 (ctbp2). [source:swissprot;acc:p56545]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
192.977\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01655\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BCL6B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
b-cell cll/lymphoma 6, member b (zinc finger protein); zinc finger protein 62. [source:refseq;acc:nm\_181844]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.191\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
192.996\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GATAD2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
p66 alpha. [source:refseq;acc:nm\_017660]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
167.687\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
170.455\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01651\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GATAD2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription repressor p66 beta component of the mecp1 complex. [source:refseq;acc:nm\_020699]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tyrosine aminotransferase (ec 2.6.1.5) (l-tyrosine:2-oxoglutarate aminotransferase) (tat). [source:swissprot;acc:p17735]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5C1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase gamma chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p36542]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.277\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.739\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01648\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5O\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase oligomycin sensitivity conferral protein, mitochondrial precursor (ec 3.6.3.14) (oscp). [source:swissprot;acc:p48047]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF3K\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 11 (eif-3 p25) (eif3k) (muscle specific gene m9 protein) (ptd001) (hspc029) (arg134). [source:swissprot;acc:q9ubq5]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01646\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLMO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
erythroid differentiation and denucleation factor 1. [source:swissprot;acc:o60584]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BBS7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bardet-biedl syndrome 7 protein isoform a; bbs2-like 1. [source:refseq;acc:nm\_176824]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1568\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
ba508n22.1 (hspc025) (fragment). [source:sptrembl;acc:q9hcw5]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1569\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLMO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein c20orf45 (cgi-107). [source:swissprot;acc:q9y3b1]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF3EIP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 6 interacting protein (hspc021/hspc025). [source:swissprot;acc:q9y262]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative rna-binding protein 7 (rna binding motif protein 7). [source:swissprot;acc:q9y580]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
R3HDM1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
r3h domain protein 1. [source:swissprot;acc:q15032]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.573\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tata element modulatory factor (tmf). [source:swissprot;acc:p82094]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.585\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.982\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01645\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCYL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
scy1-like 1; telomerase regulation-associated protein; ht019 protein; telomerase regulation-associated protein; n-terminal kinase-like protein; teratoma-associated tyrosine kinase; n-terminal kinase-like. [source:refseq;acc:nm\_020680]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUP98\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear pore complex protein nup98 (nucleoporin nup98) (98 kda nucleoporin). [source:swissprot;acc:p52948]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AMMECR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ammecr1 protein. [source:refseq;acc:nm\_015365]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAE1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mrna-associated protein mrnp 41 (rae1 protein homolog). [source:swissprot;acc:p78406]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TATDN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cda11 protein. [source:refseq;acc:nm\_032026]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.732\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01644\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCNB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.018\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.769\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01637\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDK3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cell division protein kinase 3 (ec 2.7.1.-). [source:swissprot;acc:q00526]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.753\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/